Progress Report on Studies of FAM-CF for Gastric Cancer and Intraperitoneal Administration of FUra-CF Followed by Cisplatin (DDP)
作者： S. G. Arbuck , H. O. Douglass , H. R. Nava , Y. N. Silk , M. Baroni
DOI: 10.1007/978-1-4684-5607-3_31
关键词:
摘要: Randomized controlled trials have demonstrated that the response rate to 5-fluorouracil (FUra) in combination with leucovorin (CF) is approximately two-fold higher than single agent FUra patients colorectal carcinoma (1–5). Since alone has activity other gastrointestinal cancers, our work been directed toward evaluating role of this for treatment using both intravenous (IV) and intraperitoneal (IP) routes.
springer.com
sci-hub.st 参考文章(14)
Michael J. O’Connell, A Controlled Clinical Trial Including Folinic Acid at Two Distinct Dose Levels in Combination with 5-Fluorouracil (5FU) for the Treatment of Advanced Colorectal Cancer: Experience of the Mayo Clinic and North Central Cancer Treatment Group Advances in Experimental Medicine and Biology. ,vol. 244, pp. 173- 184 ,(1988) , 10.1007/978-1-4684-5607-3_18
Fluoropyrimidines in Cancer Chemotherapy, John J. McGuire, Youcef M. Rustum, The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy ,(2012)
Paul H. Sugarbaker, Jerry M. Collins, Robert L. Dedrick, Charles E. Myers, James L. Speyer, Raymond W. Klecker, Portal Levels and Hepatic Clearance of 5-Fluorouracil after Intraperitoneal Administration in Humans Cancer Research. ,vol. 41, pp. 1916- 1922 ,(1981)
James H. Doroshow, Karen R. Grotzinger, Gershon Y. Locker, Robert F. Ozols, Charles E. Myers, Robert C. Young, Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Research. ,vol. 39, pp. 3209- 3214 ,(1979)
D Machover, E Goldschmidt, P Chollet, G Metzger, J Zittoun, J Marquet, J M Vandenbulcke, J L Misset, L Schwarzenberg, J B Fourtillan, Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. Journal of Clinical Oncology. ,vol. 4, pp. 685- 696 ,(1986) , 10.1200/JCO.1986.4.5.685
I. Taylor, D. Machin, M. Mullee, G. Trotter, T. Cooke, C. West, A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. British Journal of Surgery. ,vol. 72, pp. 359- 363 ,(2005) , 10.1002/BJS.1800720509
NR Dunnick, RB Jones, JL Doppman, J Speyer, CE Myers, Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics American Journal of Roentgenology. ,vol. 133, pp. 221- 223 ,(1979) , 10.2214/AJR.133.2.221
John S Macdonald, Philip S Schein, Paul V Woolley, Tarilyn Smythe, Winston Ueno, Daniel Hoth, Frederick Smith, MICHEL BOIRON, CHRISTIAN GISSELBRECHT, RENE BRUNET, CLAUDE LAGARDE, None, 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric Cancer Annals of Internal Medicine. ,vol. 93, pp. 533- 536 ,(1980) , 10.7326/0003-4819-93-4-533
N Petrelli, L Herrera, Y Rustum, P Burke, P Creaven, J Stulc, L J Emrich, A Mittelman, A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. Journal of Clinical Oncology. ,vol. 5, pp. 1559- 1565 ,(1987) , 10.1200/JCO.1987.5.10.1559
Vincent T. DeVita, Jerry M. Collins, Alan R. Buckpitt, Robert L. Dedrick, Murray F. Brennan, Charles E. Myers, James L. Speyer, Harold Londer, Phase I and Pharmacological Studies of 5-Fluorouracil Administered Intraperitoneally Cancer Research. ,vol. 40, pp. 567- 572 ,(1980)